Vivek Subbiah/LinkedIn
Mar 12, 2025, 14:49
Vivek Subbiah: ASCO 2025 Annual meeting is shaping up to be incredible
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“ASCO 2025 Annual meeting is shaping up to be incredible!
With the amazing Scientific Chair Erika Hamilton and terrific Educational Chair Cardinale B. Smith curating the latest and greatest in oncology, it’s sure to be an event to remember. Can’t wait!
And… what an amazing crew of clinical trialists to hang out with.
So much fun to connect with these incredible minds at the ASCO headquarters as part of the Developmental Therapeutics group.
A few of these cool cutting-edge drugs in oncology today could be plenary talks 5 years from now! We can see the future.”
More posts featuring Vivek Subbiah.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 20, 2025, 17:47
Mar 20, 2025, 17:37
Mar 20, 2025, 17:29
Mar 20, 2025, 16:59
Mar 20, 2025, 15:17